Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational... by Derikx, Lauranne A A P, Dolby, Heather W, Plevris, Nikolas, Lucaciu, Laura, Rees, Caitlin S, Lyons, Mathew, Siakavellas, Spyros I, Constantine-Cooke, Nathan, Jenkinson, Philip, Su, Shanna, O’Hare, Claire, Kirckpatrick, Laura, Merchant, Lynne M, Noble, Colin, Arnott, Ian D, Jones, Gareth-Rhys, Lees, Charlie W

Get full text